European Association for the Study of the Liver, Clinical Practice Guideline Panel (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. Journal of hepatology, 75(3), pp. 659-689. Elsevier 10.1016/j.jhep.2021.05.025
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Berzigotti_Annalisa_Chair_of_Panel_EASL.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy |
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1600-0641 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Rahel Fuhrer |
Date Deposited: |
01 Dec 2021 13:54 |
Last Modified: |
01 Dec 2021 13:54 |
Publisher DOI: |
10.1016/j.jhep.2021.05.025 |
PubMed ID: |
34166721 |
Additional Information: |
Berzigotti Annalisa, Author and Chair of Panel |
Uncontrolled Keywords: |
NASH cirrhosis decompensation elastography serum markers of fibrosis |
BORIS DOI: |
10.48350/161224 |
URI: |
https://boris.unibe.ch/id/eprint/161224 |
Actions (login required)
 |
Edit item |